Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.21 Insider Own0.20% Shs Outstand73.25M Perf Week-4.92%
Market Cap665.84M Forward P/E- EPS next Y-0.12 Insider Trans44.19% Shs Float24.37M Perf Month-2.05%
Income-15.40M PEG- EPS next Q-0.14 Inst Own28.70% Short Float42.25% Perf Quarter-21.09%
Sales191.20M P/S3.48 EPS this Y-86.60% Inst Trans-3.24% Short Ratio19.20 Perf Half Y-11.40%
Book/sh3.69 P/B2.46 EPS next Y58.60% ROA-2.10% Target Price14.40 Perf Year-34.32%
Cash/sh1.93 P/C4.70 EPS next 5Y28.00% ROE-2.60% 52W Range8.70 - 15.06 Perf YTD-1.20%
Dividend- P/FCF81.20 EPS past 5Y16.50% ROI2.40% 52W High-40.07% Beta0.95
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin87.90% 52W Low3.74% ATR0.36
Employees423 Current Ratio3.10 Sales Q/Q-38.40% Oper. Margin-8.00% RSI (14)35.38 Volatility3.15% 3.89%
OptionableYes Debt/Eq0.00 EPS Q/Q-239.30% Profit Margin-3.70% Rel Volume0.96 Prev Close9.09
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout- Avg Volume536.26K Price9.02
Recom2.00 SMA20-3.28% SMA50-12.89% SMA200-17.16% Volume118,572 Change-0.72%
Aug-04-17Reiterated RBC Capital Mkts Outperform $16 → $14
May-10-17Downgrade Piper Jaffray Overweight → Neutral
Dec-21-16Reiterated RBC Capital Mkts Outperform $23 → $16
Sep-22-16Reiterated RBC Capital Mkts Outperform $32 → $26
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Sep-15-17 12:27PM  Montel Williams' Battle With Multiple Sclerosis And The Miracle Of Medical Marijuana Benzinga
08:33AM  Of the 14 Largest Marijuana Stocks, Only These 2 Are Down Over the Past Year Motley Fool
Sep-14-17 06:26PM  ETFs with exposure to INSYS Therapeutics, Inc. : September 14, 2017 Capital Cube
01:55PM  Company under fire for opioid marketing files patent suit Associated Press
Sep-13-17 11:41AM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017 Capital Cube
07:23AM  3 PR Scandals Creating Intriguing Buying Opportunities Motley Fool
Sep-12-17 07:55AM  Have Investors Already Priced In INSYS Therapeutics Incs (INSY) Growth? Simply Wall St.
Sep-07-17 09:49AM  [$$] Opioid Maker Bent Rules to Get Drug to Patients, Senate Report Says The Wall Street Journal
Sep-06-17 07:16PM  U.S. senator reveals results of opioid inquiry into Insys Reuters
05:48PM  U.S. senator reveals results of opioid inquiry into Insys Reuters
02:51PM  [$$] Opioid Maker Bent Rules to Get Drug to Patients, Senate Report Says The Wall Street Journal
Sep-05-17 09:31AM  Why This Marijuana Stock Crashed 18.5% in August Motley Fool
Sep-01-17 12:08PM  5 of the Most Hated Biotech Stocks on the Market: Are They Buys? Motley Fool
09:45AM  Insys Addresses Arizona Attorney General Complaint GlobeNewswire
12:30AM  [$$] Arizona Accuses Insys of Fraudulently Marketing Fentanyl Painkiller The Wall Street Journal
Aug-31-17 03:53PM  Arizona accuses drugmaker Insys of fraudulent opioid marketing Reuters
01:25PM  AG's office files lawsuit against opioid manufacturer Insys Therapeutics American City Business Journals
10:39AM  [$$] Arizona Accuses Insys of Fraudulently Marketing Fentanyl Painkiller The Wall Street Journal
10:35AM  Arizona accuses Insys of fraudulent opioid marketing scheme Reuters
Aug-24-17 07:50AM  Corporate News Blog - Insys Therapeutics Releases Statement on Illinois Settlement; Provides Data against the Opioid-Induced Calamity in the US ACCESSWIRE
Aug-22-17 06:50AM  Insys Addresses Questions Raised by Illinois Settlement GlobeNewswire
Aug-19-17 12:03PM  3 Top Biotech Stocks Under $10 Motley Fool
Aug-18-17 03:27PM  Insys agrees to pay $4.45 mln to resolve Illinois opioid lawsuit Reuters
02:27PM  Insys agrees to pay $4.5 mln to resolve Illinois opioid lawsuit Reuters
Aug-14-17 08:34AM  This Struggling Marijuana Stock Finally Launched Its Highly Anticipated Drug Motley Fool
Aug-13-17 09:03AM  3 Marijuana Stocks That Could Make You the Most Money in the 2nd Half of 2017 Motley Fool
Aug-12-17 09:20AM  Edited Transcript of INSY earnings conference call or presentation 3-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 09:49AM  Nevro's (NVRO) Q2 Loss Wider than Expected, Revenues Beat Zacks
Aug-09-17 09:46AM  BioScrip (BIOS) Q2 Loss Wider Than Expected, Revenues Miss Zacks
09:42AM  BioTelemetry (BEAT) Q2 Earnings Top, Revenues Meet Estimates Zacks
09:20AM  Myriad Genetics (MYGN) Beats on Q4 Earnings & Revenues Zacks
08:32AM  Penumbra (PEN) Loss Meets Estimates, Revenues Beat in Q2 Zacks
08:32AM  This Marijuana Stock Skyrocketed Last Week, While 3 Others Plunged Motley Fool
Aug-08-17 10:14AM  Henry Schein (HSIC) Q2 Earnings & Revenues Beat, View Intact Zacks -6.62%
08:50AM  Orthofix (OFIX) Earnings Meet, Sales Beat Estimates in Q2 Zacks
08:31AM  Haemonetics (HAE) Q1 Earnings Beat, Revenues Miss Estimates Zacks
08:17AM  Bio-Rad (BIO) Misses Q2 Earnings & Sales, Margin Declines Zacks
Aug-07-17 08:25AM  Insulet (PODD) Shows Strength: Stock Adds 7.1% in Session Zacks
07:43AM  Cardiovascular Systems Rides on Innovation Amid Several Woes Zacks
Aug-04-17 04:32PM  Pacific Biosciences (PACB) Posts Wider-than-Expected Q2 Loss Zacks
09:26AM  Wright Medical Group (WMGI) Q2 Loss Narrower than Expected Zacks
09:23AM  Inogen (INGN) Beats Earnings and Revenue Estimates in Q2 Zacks
08:50AM  Illumina (ILMN) Rides on New Products, Low Margin a Concern Zacks
08:49AM  Bruker (BRKR) Q2 Earnings & Revenues Beat Estimates, View Up Zacks
Aug-03-17 11:53PM  Insys Therapeutics reports 2Q loss Associated Press -8.91%
05:09PM  It's High Time For The Cannabis-Related Drug Pipeline Benzinga
12:10PM  Insys takes $4.5 million charge to settle Illinois opioid lawsuit Reuters
08:36AM  Agios Pharmaceuticals (AGIO) Looks Good: Stock Adds 5.1% in Session Zacks
08:09AM  Cardiovascular Systems (CSII) Posts Q4 Earnings, Revenues Top Zacks
06:50AM  Insys Therapeutics Reports Second Quarter 2017 Results GlobeNewswire
06:15AM  Investor Network: Insys Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 10:25AM  Illumina (ILMN) Tops Q2 Earnings & Revenues, Raises View Zacks
08:16AM  DaVita (DVA) Beats Earnings and Revenue Estimates in Q2 Zacks
Aug-01-17 10:35AM  VWR Corp (VWR) Beats Earnings & Revenue Estimates in Q2 Zacks
10:29AM  IDEXX Laboratories (IDXX) Q2 Earnings & Revenues Top, View Up Zacks
09:54AM  Hill-Rom Holdings (HRC) Beats Q3 Earnings, Misses Revenues Zacks
Jul-31-17 09:07AM  NuVasive (NUVA) Beats on Q2 Earnings, Retains 2017 View Zacks
09:03AM  Omnicell (OMCL) Earnings Meet, Revenues Beat Estimates in Q2 Zacks
08:20AM  LeMaitre Vascular (LMAT) Worth a Look: Stock Jumps 19.5% Zacks
06:50AM  Insys Announces Availability of SYNDROS, the First and Only FDA-Approved Liquid Dronabinol, by Prescription GlobeNewswire
Jul-28-17 04:32PM  ETFs with exposure to INSYS Therapeutics, Inc. : July 28, 2017 Capital Cube
11:15AM  Abaxis (ABAX) Misses Earnings & Revenue Estimates in Q1 Zacks
11:04AM  GNC Holdings (GNC) Tops Q2 Earnings, Misses Sales Estimates Zacks
09:48AM  Align Technology (ALGN) Beats on Q2 Earnings and Revenues Zacks
09:46AM  QIAGEN (QGEN) Beats on Earnings & Sales in Q2, Raises View Zacks
Jul-27-17 12:14PM  McKesson (MCK) Misses Earnings Estimates in Q1, Raises View Zacks
09:17AM  Integra LifeSciences (IART) Q2 Earnings Meet, Revenues Miss Zacks
09:05AM  CONMED (CNMD) Earnings Meet, Revenues Beat Estimates in Q2 Zacks
Jul-26-17 11:04AM  LabCorp (LH) Beats on Q2 Earnings and Sales, Guidance Up Zacks
09:17AM  Chemed (CHE) Q2 Earnings & Revenues Rise Y/Y, View Revised Zacks
08:47AM  Express Scripts (ESRX) Earnings Top in Q2, FY17 View Up Zacks
Jul-25-17 08:29AM  PetMed Express (PETS) Tops Earnings, Revenue Estimates in Q1 Zacks
Jul-23-17 08:15AM  3 Beaten-Up Biotechs Bouncing Back in 2017 (Hint: One Is a Marijuana Stock) Motley Fool
Jul-20-17 09:07AM  Quest Diagnostics Closes Deal to Acquire 2 Labs in Texas Zacks
06:50AM  Insys Therapeutics to Report Second Quarter 2017 Results on August 3, 2017 GlobeNewswire
Jul-18-17 01:54PM  ETFs with exposure to INSYS Therapeutics, Inc. : July 18, 2017 Capital Cube
10:18AM  Align Technology Hits a 52-Week High on Solid Prospects Zacks
09:30AM  Medtronic InterStim System Shows Five-Year Positive Results Zacks
06:50AM  Insys Therapeutics, Inc. Appoints Andrew G. Long as Chief Financial Officer GlobeNewswire
06:30AM  3 Healthcare Stocks for Ambitious Investors Motley Fool
Jul-17-17 01:59PM  INSYS Therapeutics, Inc. Value Analysis (NASDAQ:INSY) : July 17, 2017 Capital Cube
10:00AM  Company News for July 17, 2017 Zacks
08:07AM  Hill-Rom (HRC) at 52-Week High: What's Driving the Stock? Zacks
06:50AM  Insys Therapeutics, Inc. Releases Statement on Payor Interactions GlobeNewswire
Jul-14-17 03:51PM  Cannabis Industry Weekly Recap 7/14/2017 Forbes -5.00%
02:07PM  Here's the spiel one drug company allegedly used to push its opioids on Americans Business Insider
12:34AM  [$$] Anthem Files Civil Suit Against Insys Therapeutics The Wall Street Journal
Jul-13-17 07:21PM  Anthem files lawsuit against Insys Therapeutics Reuters
06:46PM  Anthem files lawsuit against Insys Therapeutics Reuters
06:39PM  [$$] Anthem Files Civil Suit Against Insys Therapeutics The Wall Street Journal
09:45AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : July 13, 2017 Capital Cube
Jul-12-17 04:54PM  Why Barnes & Noble Education, MSC Industrial Direct, and Insys Therapeutics Slumped Today Motley Fool -8.44%
12:01PM  It's been a brutal week for the most shameless company in the opioid crisis and it's about to get worse Business Insider
12:41AM  [$$] Ex-Insys Saleswomen Plead Guilty in Opioid Prescription Kickback Schemes The Wall Street Journal
Jul-11-17 09:59PM  Ex-Insys saleswomen plead guilty in U.S. to drug kickback schemes Reuters
05:40PM  Ex-Insys CEO's wife pleads guilty in U.S. to opioid kickback scheme Reuters
08:00AM  Today's Research Reports on Trending Tickers: Insys Therapeutics and Zynerba Pharmaceuticals Accesswire
Jul-10-17 01:46PM  Ex-Insys employee in U.S. kickback case loses fight to smoke pot Reuters
Jul-09-17 09:15AM  Will These Be the Top Marijuana Stocks to Own in 2018? Motley Fool
Jul-07-17 03:02PM  ETFs with exposure to INSYS Therapeutics, Inc. : July 7, 2017 Capital Cube
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is SYNDROS, an orally administered liquid formulation of dronabinol for treating CINV and anorexia associated with weight loss in patients with AIDS. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHN N KAPOOR TRUST DATED SEPT10% OwnerAug 11Buy8.9317,500156,33842,447,810Aug 14 12:38 PM
Motahari SaeedPresident & CEOAug 10Buy8.925,50049,05615,400Aug 10 02:42 PM
FOURTEAU PATRICKDirectorAug 04Option Exercise1.6210,00016,20069,682Aug 04 05:33 PM
Motahari SaeedPresident & CEOJun 14Buy11.105,40059,9559,900Jun 14 03:19 PM
Vishnoi RohitDirectorJun 01Buy14.144,00056,5754,000Jun 02 03:14 PM
FOURTEAU PATRICKDirectorMay 26Option Exercise3.6310,00036,30059,682May 26 04:26 PM
MEYER STEVEN JDirectorMay 18Buy12.218,00097,68052,083May 18 04:48 PM
Motahari SaeedPresident & CEOMay 16Buy11.984,50053,9324,500May 16 08:53 PM
MEYER STEVEN JDirectorNov 04Buy10.7510,000107,48944,083Nov 07 10:14 AM